EnSpectra Health

Mountain View, United States Founded: 2014 • Age: 12 yrs
Developer of medical devices for tissue imagining and cancer detection

About EnSpectra Health

EnSpectra Health is a Healthcare company based in Mountain View (United States) founded in 2014. Developer of medical devices for tissue imagining and cancer detection. EnSpectra Health has raised $15.55 million across 7 funding rounds from investors including HHS, SBIR and Foothill Ventures. The company has 8 employees. EnSpectra Health offers products and services including VIO. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ENSPECTRA HEALTH, INC. Its competitors include PathAI, PAIGE and Proscia; 3 of its 3 listed competitors have raised funding.

Company details

EnSpectra Health is a provider of medical tools and devices that assists in detecting cancer in skin tissue cells. The devices are provided to dermatologists for tissue imaging. The company provides a pulsed laser microscope, that allows professionals to look for into the tissue cells. The products help in the detection and characterization of tumor tissue in other medical fields such as Gastroenterology, Surgical Oncology, and Gynecology.

  • Headquarters Mountain View, United States
  • Employees 8
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website enspectrahealth.com
  • Social LinkedIn
  • Legal Name Enspectra Health, Inc
Key Metrics
  • Total Equity Funding
    $15.55M (USD)

    in 7 rounds

  • Latest Funding Round
    $2M (USD), Grant

    Jul 2023

  • Investors
    HHS

    & 2 more

  • Employee Count
    8

Products & Services of EnSpectra Health

EnSpectra Health offers a comprehensive portfolio of products and services, including VIO.

VIO
Skin Imaging System

Non-invasive device for real-time skin cellular visualization and diagnostics.

Funding Insights of EnSpectra Health

EnSpectra Health has successfully raised a total of $15.55M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $15.55M
  • Total Rounds 7
  • Last Round Grant β€” $2M
  • First Round $700,000

    (Feb 2015)

  • Investors Count 3

All 7 funding rounds of EnSpectra Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2023$2MGrant––
Jul 2023$2MGrant––
May 2021$4MGrant––
Mar 2019$7.5MSeries A–Foothill Ventures
–
Feb 2019$7.35MSeries A––
–
Sep 2017$5.94MGrant––
Feb 2015$700,000Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in EnSpectra Health

EnSpectra Health has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, SBIR and Foothill Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund focused on pre-seed tech startups
foothill.venturesLos Altos, United States
Federal innovation and scientific achievement services are provided.
1982sbir.govLithia Springs, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for EnSpectra Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of EnSpectra Health

3 people are tracked at EnSpectra Health (2 in leadership, 1 in team); the tracked headcount is 8.

NameRoleGroup
Gabriel Sanchez
CEOLeadership
Grace Kao Li
Vp, Quality And RegulatoryLeadership
Ryan Belcher
ConsultantTeam
Premium access

Complete people profiles for EnSpectra Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of EnSpectra Health

3 dated milestones of EnSpectra Health across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded EnSpectra Health is founded.
  2. Funding First funding round of $700K.
  3. Funding Latest funding round, Grant, of $2.0M.

Competitors of EnSpectra Health

EnSpectra Health has 3 listed competitors in our database, 3 of them funded. They include PathAI, PAIGE and Proscia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
paige.ai2018New York, United States$241M
AI-enabled tools for computational pathology and cancer diagnostics are provided.
proscia.com2014Philadelphia, United States$129.23M85
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
Premium access

Detailed competitors of EnSpectra Health

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as EnSpectra Health (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Enspectra Health

Premium access

Complete news archive for EnSpectra Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EnSpectra Health

EnSpectra Health was founded in 2014 and raised its 1st funding round 1 year after it was founded.

EnSpectra Health is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

EnSpectra Health is a funded company, having raised a total of $15.55M across 7 funding rounds to date. The company's 1st funding round was a Seed of $700K, raised on Feb 2015.

EnSpectra Health has 8 employees.

EnSpectra Health is a provider of medical tools and devices that assists in detecting cancer in skin tissue cells. The devices are provided to dermatologists for tissue imaging. The company provides a pulsed laser microscope, that allows professionals to look for into the tissue cells. The products help in the detection and characterization of tumor tissue in other medical fields such as Gastroenterology, Surgical Oncology, and Gynecology.

EnSpectra Health's top competitors include PathAI, PAIGE and Proscia.

EnSpectra Health offers VIO.

EnSpectra Health has 3 investors. Key investors include HHS, SBIR, and Foothill Ventures.

EnSpectra Health operates through Enspectra Health, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available